MARINUS PHARMACEUTICALS INC's ticker is and the CUSIP is 56854Q200. A total of 75 filers reported holding MARINUS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 4,222,648 | $21,480,000 | 3.06% |
| Bleichroeder LP | 1,872,463 | $7,452,403 | 1.62% |
| VR Adviser, LLC | 1,770,705 | $7,047,406 | 1.19% |
| Opaleye Management Inc. | 826,200 | $3,288,276 | 1.14% |
| Islet Management, LP | 400,000 | $1,592,000 | 1.07% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,822,995 | $19,195,520 | 0.81% |
| Bain Capital Life Sciences Investors, LLC | 1,431,058 | $5,696 | 0.64% |
| Islet Management, LP | 200,000 | $796,000 | 0.54% |
| Eventide Asset Management | 3,150,000 | $12,537,000 | 0.25% |
| Tejara Capital Ltd | 95,828 | $381,395 | 0.22% |